Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Barbara Guerrera"'
Autor:
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi
Publikováno v:
JGH Open, Vol 4, Iss 4, Pp 713-721 (2020)
Abstract Background and Aim The impact of hepatitis C virus (HCV) clearance by direct‐acting antiviral agents (DAAs) on HCV‐related extrahepatic manifestations is not well known. We evaluated the effect of viral clearance on metabolic and renal p
Externí odkaz:
https://doaj.org/article/0de50a55ebca469589df8daa9faab494
Autor:
Luca Rinaldi, Alessandro Perrella, Maria Guarino, Massimo De Luca, Guido Piai, Nicola Coppola, Pia Clara Pafundi, Fortunato Ciardiello, Morena Fasano, Erika Martinelli, Giovanna Valente, Riccardo Nevola, Caterina Monari, Lucia Miglioresi, Barbara Guerrera, Massimiliano Berretta, Ferdinando Carlo Sasso, Filomena Morisco, Antonio Izzi, Luigi Elio Adinolfi
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background An unexpected increased HCC recurrence and occurrence rate among HCV patients treated with direct acting antivirals combination has been reported. Aim of the study was the evaluation of early HCC occurrence rate and its risk facto
Externí odkaz:
https://doaj.org/article/655ab2e6cc7c4f1bb92ef1c261816e9d
Autor:
Ferdinando Carlo Sasso, Letizia Zeni, Aldo Marrone, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Luca Rinaldi, Mauro Giordano, Barbara Guerrera
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 4, Iss 4, Pp 713-721 (2020)
JGH Open, Vol 4, Iss 4, Pp 713-721 (2020)
Background and Aim The impact of hepatitis C virus (HCV) clearance by direct‐acting antiviral agents (DAAs) on HCV‐related extrahepatic manifestations is not well known. We evaluated the effect of viral clearance on metabolic and renal parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5301d265d37069bca415b5e365c6b97c
https://doi.org/10.1002/jgh3.12324
https://doi.org/10.1002/jgh3.12324
Autor:
Vito Di Marco, Vincenza Calvaruso, Salvatore Petta, Mariarosaria Saturnino, Riccardo Nevola, Pia Clara Pafundi, Ferdinando Carlo Sasso, Carmine Coppola, Graziano Troina, Aldo Marrone, Francesca Rini, Laura Staiano, Anna Ludovica Fracanzani, Barbara Guerrera, Mauro Giordano, Luigi Elio Adinolfi, Vincenzo Narciso, Rosa Lombardi, Luca Rinaldi, Antonio Craxì, Antonio Solano
Publikováno v:
Atherosclerosis. 296:40-47
Background and aims: HCV is associated with an increased risk of cardiovascular events (CV). Whether HCV clearance by direct-acting antivirals (DAA) reduces incident CV disease is poorly understood. We investigate whether HCV eradication reduces CV e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66db58249ecddb89e56032a7daead55b
https://doi.org/10.1016/j.atherosclerosis.2020.01.010
https://doi.org/10.1016/j.atherosclerosis.2020.01.010
Autor:
Luigi Elio Adinolfi, Luca Del Viscovo, Luca Rinaldi, Annalisa Chianese, Veronica Folliero, Luciano Restivo, Serena De Luca, Barbara Guerrera, Natalina Iuliano, Gianluigi Franci, Francesco Foglia
Publikováno v:
The American Journal of Case Reports
Patient: Male, 58-year-old Final Diagnosis: Fasciola hepatica infection Symptoms: Jaundice • fatigue • anorexia • subjective weight loss Medication: — Clinical Procedure: — Specialty: General and Internal Medicine Objective: Background: Cas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::644a85dbbf54cb516b89869b709a187c
https://pubmed.ncbi.nlm.nih.gov/32936789
https://pubmed.ncbi.nlm.nih.gov/32936789
Autor:
Ferdinando Carlo Sasso, Salvatore Petta, Antonio Solano, Vito Di Marco, Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone, Riccardo Nevola, Graziano Troina, Mauro Giordano, Anna Ludovica Fracanzani, Antonio Craxì, Mariarosaria Saturnino, Pia Clara Pafundi, Francesca Rini, Laura Staiano, Carmine Coppola, Barbara Guerrera, Vincenza Calvaruso, Rosa Lombardi, Vincenzo Narciso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dc449795a23f249f7a62f359385ccda
https://doi.org/10.1111/dom.14168/v2/response1
https://doi.org/10.1111/dom.14168/v2/response1
Autor:
Antonio Solano, Anna Ludovica Fracanzani, Ferdinando Carlo Sasso, Salvatore Petta, Pia Clara Pafundi, Antonio Craxì, Riccardo Nevola, Barbara Guerrera, Carmine Coppola, Vito Di Marco, Rosa Lombardi, Vincenzo Narciso, Aldo Marrone, Vincenza Calvaruso, Luigi Elio Adinolfi, Luca Rinaldi, Mariarosaria Saturnino, Mauro Giordano, Francesca Rini, Laura Staiano, Graziano Troina
Aim HCV infection increases the risk of type 2 diabetes mellitus (T2DM). However, it remains still unclear whether HCV clearance by direct-acting antivirals (DAA) reduces T2DM. Therefore, the effect of HCV eradication on T2DM incidence was assessed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f86f20614d9d74ecd378aeb7239ce5a0
http://hdl.handle.net/10447/509988
http://hdl.handle.net/10447/509988
Autor:
Luigi Elio Adinolfi, Aldo Marrone, Luca Rinaldi, Giovanni D'Alterio, Barbara Guerrera, Mauro Giordano, Riccardo Nevola
Publikováno v:
Journal of Gastroenterology and Hepatology. 33:1379-1382
BACKGROUND AND AIM Chronic hepatitis C virus (HCV), particularly genotype 1, is associated with insulin resistance (IR) and diabetes. This study evaluated the impact of HCV clearance by all-oral direct-acting antiviral treatments on IR and glycemic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3006c458cba41db695d1ee23484b7b3
https://doi.org/10.1111/jgh.14067
https://doi.org/10.1111/jgh.14067
Autor:
Giovanna Valente, Alessio Trabucco, Barbara Guerrera, Ferdinando Carlo Sasso, Maria Guarino, Luigi Elio Adinolfi, Michele Imparato, Pia Clara Pafundi, Luca Rinaldi, Riccardo Nevola, Antonio Ascione, Natalina Iuliano, Alessandro Perrella, Filomena Morisco, Guido Piai, Luca Fontanella
The aim of this study was to evaluate the relationship between the liver stiffness measurement and the risk of developing hepatocellular carcinoma (HCC) in HCV cirrhotic patients undergoing new direct-acting antivirals.From April 2015 to April 2017,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df90548fb996974a594f8f2ce0e276ea
http://hdl.handle.net/11591/405096
http://hdl.handle.net/11591/405096
Autor:
Maria Guarino, Nicola Coppola, Luigi Elio Adinolfi, Guido Piai, Massimo De Luca, Antonio Izzi, Morena Fasano, Luca Rinaldi, Fortunato Ciardiello, Ferdinando Carlo Sasso, Riccardo Nevola, Filomena Morisco, Giovanna Valente, Alessandro Perrella, Caterina Monari, Pia Clara Pafundi, Lucia Miglioresi, Erika Martinelli, Barbara Guerrera, Massimiliano Berretta
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background An unexpected increased HCC recurrence and occurrence rate among HCV patients treated with direct acting antivirals combination has been reported. Aim of the study was the evaluation of early HCC occurrence rate and its risk factors in a H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53a538f4e3aa5ef7fca143ee5189501
http://hdl.handle.net/11591/414420
http://hdl.handle.net/11591/414420